Current Cancer Drug Targets

Papers
(The H4-Index of Current Cancer Drug Targets is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Old and New Approaches to Target the Hsp90 Chaperone101
Targeting Proliferating Cell Nuclear Antigen (PCNA) as an Effective Strategy to Inhibit Tumor Cell Proliferation84
Targeting Different Pathways Using Novel Combination Therapy in Triple Negative Breast Cancer77
COVID-19 Pandemic: Experiences in China and Implications for its Prevention and Treatment Worldwide31
Cancer Cell-derived Secretory Factors in Breast Cancer-associated Lung Metastasis: Their Mechanism and Future Prospects24
The Role of RNA Modifications and RNA-modifying Proteins in Cancer Therapy and Drug Resistance21
Nanotechnology-enabled Chemodynamic Therapy and Immunotherapy20
Crosstalk of Long Non-coding RNAs and EMT: Searching the Missing Pieces of an Incomplete Puzzle for Lung Cancer Therapy20
Effects of Intermittent Hypoxia on Expression of Glucose Metabolism Genes in MCF7 Breast Cancer Cell Line20
CircRNA SCARB1 Promotes Renal Cell Carcinoma Progression Via Mir- 510-5p/SDC3 Axis19
The Therapeutic Potential of MAPK/ERK Inhibitors in the Treatment of Colorectal Cancer19
Role of Tumor Microenvironment in Cancer Stem Cells Resistance to Radiotherapy19
Protectors of the Mitochondrial Permeability Transition Pore Activated by Iron and Doxorubicin17
Role of ZEB Family Members in Proliferation, Metastasis, and Chemoresistance of Prostate Cancer Cells: Revealing Signaling Networks16
Exosome as a Natural Gene Delivery Vector for Cancer Treatment14
Targeting IDH Mutations in AML: Wielding the Double-edged Sword of Differentiation14
The Potential of Natural Products in the Treatment of Triple-negative Breast Cancer14
C-Myc Signaling Pathway in Treatment and Prevention of Brain Tumors14
MUC Glycoproteins: Potential Biomarkers and Molecular Targets for Cancer Therapy14
0.026324987411499